文献速递腹部US

点剪切波弹性成像与瞬时弹性成像评估非酒精性脂肪性肝病患者的比较

Comparison of point shear wave elastography and transient elastography in the evaluation of patients with NAFLD.
PubMed 文献 · Radiol Med · 2022-03-15

前瞻性研究纳入50例非酒精性脂肪性肝病患者,在同一次评估中完成临床评估、B型超声、点剪切波弹性成像(pSWE)、瞬时弹性成像(TE)和肝活检,比较两种弹性成像与肝活检诊断肝纤维化分期的效能。仅纤维化分期与TE和pSWE独立相关;TE诊断≥F2的AUROC显著优于pSWE,而≥F1、≥F3和F4的AUROC两者无统计学显著差异。

要点

  • TE诊断≥F2的AUROC为0.867,pSWE为0.733,TE显著优于pSWE。
  • TE与pSWE诊断F4的AUROC分别为0.990和1.000,两者无统计学显著差异。
  • 仅纤维化分期与TE和pSWE独立相关,其他组织学参数无关联。

核心结论

  • TE诊断纤维化分期≥F2的效能显著优于pSWE;诊断≥F1、≥F3和F4时,TE与pSWE的AUROC无统计学显著差异。

研究设计与样本

  • 前瞻性研究,2017年9月至2020年10月连续纳入50例非酒精性脂肪性肝病患者(52.2±13.0岁,32例男性),所有患者在同一次评估中接受临床评估、B型超声、pSWE(ElastPQ®)、TE和肝活检,以肝活检为参考标准。

诊断标准与关键数值

  • TE诊断F1、≥F2、≥F3、F4的AUROC分别为0.795、0.867、0.927、0.990。
  • pSWE诊断F1、≥F2、≥F3、F4的AUROC分别为0.717、0.733、0.908、1.000。
  • TE测得F0、F1、F2、F3、F4期的肝脏硬度中位数分别为4.8(4.7-6.1)kPa、5.5(4.4-7.3)kPa、7.7(6.1-9.1)kPa、9.9(8.8-13.8)kPa、20.2 kPa。
  • pSWE测得F0、F1、F2、F3、F4期的肝脏硬度中位数分别为4.2(4.0-4.8)kPa、4.7(4.2-5.8)kPa、5.1(4.1-6.9)kPa、8.5(5.2-13.3)kPa、15.1 kPa。

临床应用与阅片要点

  • 在非酒精性脂肪性肝病纤维化分期评估中,TE诊断≥F2的效能显著优于pSWE。
  • 诊断≥F1、≥F3和F4时,TE与pSWE的AUROC无统计学显著差异。
  • 仅纤维化分期与TE和pSWE独立相关,其他组织学参数与两者无关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare point shear wave elastography (pSWE, ElastPQ®) and transient elastography (TE) with Liver Biopsy in order to evaluate fibrosis stage in non-alcoholic fatty liver disease (NAFLD).

METHODS: Our prospective study from September 2017 to October 2020 included 50 consecutively enrolled patients with NAFLD (52.2 ± 13.0 years, 32 male). All patients underwent clinical evaluation, B-mode ultrasound, pSWE, TE and liver biopsy in a single evaluation. The clinical, laboratory and liver biopsy data were compared with liver stiffness (LS) measurement obtained with pSWE and TE. TE and pSWE diagnostic accuracy for the diagnosis of the different fibrosis stages were evaluated using the area under receiver operating characteristic curve (AUROC).

RESULTS: Only fibrosis stage was independently associated with TE and pSWE. The median liver stiffness measurement for fibrosis stages F0, F1, F2, F3, and F4 using TE was 4.8 (4.7-6.1) kPa, 5.5 (4.4-7.3) kPa, 7.7 (6.1-9.1) kPa, 9.9 (8.8-13.8) kPa, and 20.2 kPa, respectively. The corresponding median liver stiffness measurement using pSWE was 4.2 (4.0-4.8) kPa, 4.7 (4.2-5.8) kPa, 5.1 (4.1-6.9) kPa, 8.5 (5.2-13.3), and 15.1 kPa, respectively. The AUROC of TE for diagnosis of fibrosis stage F1, ≥ F2, ≥ F3, and F4 were 0.795, 0.867, 0.927, and 0.990, respectively. The corresponding AUROC of pSWE was 0.717, 0.733, 0.908, and 1.000, respectively. No association was observed with other histological parameters.

CONCLUSION: TE was significantly better than pSWE for the diagnosis of fibrosis stage ≥ F2. No statistically significant differences were found between TE and pSWE AUROC of fibrosis stage ≥ F1, ≥ F3, and F4.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Argalia G, Ventura C, Tosi N, et al. Comparison of point shear wave elastography and transient elastography in the evaluation of patients with NAFLD. Radiol Med. 2022. PMID: 35290569. doi:10.1007/s11547-022-01475-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。